What We Do – Verdant

Verdant provides economic and policy expertise across the core areas shaping U.S. prescription drug markets.

Understanding prescription drug markets requires more than data alone—it demands clear, objective assessment of the tradeoffs between access, affordability, and innovation. Verdant brings that clarity, delivering evidence-based analysis that informs high-stakes policy and business decisions.

See our work

Areas of Expertise

Policy Analysis & Development

Verdant helps public and private sector stakeholders navigate tradeoffs at the heart of U.S. drug policy reform. We apply deep policy experience and rigorous economic analysis to questions about pharmaceutical reimbursement, reporting requirements and market structure.

Economic evaluation of drug pricing, coverage, and reimbursement policy
Evidence-based analysis of reform proposals and legislative design
Tradeoff assessment across patient access, innovation, and program sustainability

Data Analytics & Modeling

Verdant’s proprietary datasets and custom economic models allow us to quantify how policy and market dynamics shape pharmaceutical pricing, access, and innovation. Our analyses ground strategic decisions in evidence.

Drug-level identification of products affected by proposed policy changes
Bottom-up impact modeling from individual drugs to sector-wide effects
Scenario analysis across Medicare, Medicaid, and commercial channels

Litigation & Expert Testimony

We bring economic and policy expertise to pharmaceutical matters where federal programs, market structure, and drug pricing are in dispute.

Expert reports, deposition, and trial testimony
Damages and economic impact analysis in federal program matters
Market structure, pricing, and competitive conduct analysis

Lead with Evidence

Partner with Verdant for rigorous, objective economic analysis.